OCUP logo

Ocuphire Pharma Inc

OCUP

$2.49

- $0.21 (-7.92%) This month

Closed: 23 Feb 2024 21:00 US/Eastern

Key details

CEO

Douglas Swirsky

Employees

14

Headquarters

Rockville, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Ocuphire Pharma Inc

ocuphire is a new biopharmaceuticals company focused on developing and commercializing small molecule drugs for unmet medical needs in the ocular disease space. ocuphire’s lead drug candidate, nyxol eye drops, is aimed to treat patients with night vision disturbances (nvd), glaucoma and presbyopia (impaired near-term vision). ocuphire is in discussions with a prospective late stage ophthalmic drug program that could be developed in parallel. ocuphire's management team has over 100 years of drug development expertise across a diverse set of therapeutic areas including ophthalmology, orphan, cardio-metabolic, nephrology, oncology and respiratory.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG